Amphastar Pharmaceuticals (AMPH) Change in Receivables (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) posted quarterly Change in Receivables of $4.5 million for Q1 2026, down 43.69% year-over-year from $8.1 million in Q1 2025, and up 240.69% quarter-over-quarter from -$3.2 million in Q4 2025.
Amphastar Pharmaceuticals (AMPH) Change in Receivables (2013 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' Change in Receivables history runs 14 years deep, the most recent figure standing at $4.5 million for Q1 2026.
- In Q1 2026, Change in Receivables fell 43.69% year-over-year to $4.5 million; the TTM figure through Mar 2026 stood at $2.8 million (down 56.62% YoY), while the FY2025 annual figure was $6.4 million, down 70.62% from the prior year.
- Change in Receivables for Q1 2026 stood at $4.5 million, up from -$3.2 million in the prior quarter.
- The five-year high for Change in Receivables was $23.2 million in Q1 2024, with the low at -$12.3 million in Q2 2025.
- The 5-year median for Change in Receivables is $4.5 million (2026), against an average of $4.0 million.
- The sharpest annual moves came in 2022 and 2024: Change in Receivables surged 1430.46% in 2022, then slumped 428.82% in 2024.
- Amphastar Pharmaceuticals' Change in Receivables stood at $11.6 million in 2022, then sank by 135.39% to -$4.1 million in 2023, then rose by 28.93% to -$2.9 million in 2024, then declined by 11.22% to -$3.2 million in 2025, then soared by 240.69% to $4.5 million in 2026.
- Business Quant data shows AMPH's Change in Receivables at $4.5 million in Q1 2026, -$3.2 million in Q4 2025, and $13.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 91.00 Mn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 66.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | -445.26 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | -1.70 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 126.50 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 84.30 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 936.60 Mn | 646.48 Mn | 93.47 Mn | -2.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.98 Mn |
| Jun 30, 2026 | -2.98 Mn |
| Mar 31, 2026 | 4.55 Mn |
| Mar 31, 2026 | 4.55 Mn |
| Dec 31, 2025 | -3.23 Mn |
| Dec 31, 2025 | -3.23 Mn |
| Sep 30, 2025 | 13.79 Mn |
| Sep 30, 2025 | 13.79 Mn |
| Jun 30, 2025 | -12.27 Mn |
| Jun 30, 2025 | -12.27 Mn |
| Mar 31, 2025 | 8.08 Mn |
| Mar 31, 2025 | 8.08 Mn |
| Dec 31, 2024 | -2.91 Mn |
| Dec 31, 2024 | -2.91 Mn |
| Sep 30, 2024 | 8.06 Mn |
| Sep 30, 2024 | 8.06 Mn |
| Jun 30, 2024 | -6.68 Mn |
| Jun 30, 2024 | -6.68 Mn |
| Mar 31, 2024 | 23.20 Mn |
| Mar 31, 2024 | 23.20 Mn |